arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2112.03352stat.ME
收藏

主分层法在临床试验分析中的应用

Using principal stratification in analysis of clinical trials

Ilya Lipkovich, Bohdana Ratitch, Yongming Qu, Xiang Zhang, Mingyang Shan, Craig Mallinckrodt

摘要:

ICH E9(R1)附录(2019)提出将主要分层(PS)作为处理并发事件的五种策略之一。因此,了解PS的优势、局限性和假设对于广大的临床试验者社区非常重要。在不同的研究领域,包括实验和观察研究,在PS的总体框架下已经开发了许多方法。这些不同的应用程序使用了不同的工具和假设。因此,需要以统一的方式提出这些办法。本教程的目标有三个方面。首先,我们提供了一个连贯和统一的描述PS。其次,我们强调,PS中的影响估计依赖于强有力的假设,我们彻底检查这些假设的后果,以了解在哪些情况下某些假设是合理的。最后,我们概述了PS分析的各种关键方法,并使用一个真实的临床试验示例来说明它们。补充材料中给出了实现这些方法的代码示例。

英文摘要:

The ICH E9(R1) addendum (2019) proposed principal stratification (PS) as one of five strategies for dealing with intercurrent events. Therefore, understanding the strengths, limitations, and assumptions of PS is important for the broad community of clinical trialists. Many approaches have been developed under the general framework of PS in different areas of research, including experimental and observational studies. These diverse applications have utilized a diverse set of tools and assumptions. Thus, need exists to present these approaches in a unifying manner. The goal of this tutorial is threefold. First, we provide a coherent and unifying description of PS. Second, we emphasize that estimation of effects within PS relies on strong assumptions and we thoroughly examine the consequences of these assumptions to understand in which situations certain assumptions are reasonable. Finally, we provide an overview of a variety of key methods for PS analysis and use a real clinical trial example to illustrate them. Examples of code for implementation of some of these approaches are given in supplemental materials.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑